Probiotical S.p.a.

Probiotical North America Inc.

Luca Mogna

Giovanni Mogna

Gian Paolo Strozzi

Lorenzo Drago

Selection of probiotic strains belonging to the genusand to a symbiotic composition containing the same for use of feeding infants, is described.

Probiotic bacterial strains and symbiotic composition containing the same intended for infant food

Selected bacterial strains belonging to the genusfor use in the treatment of hypercholesterolaemia are described. In particular, a food composition or supplement product or medical device or pharmaceutical composition has said bacterial strains in association with sterols or phytosterols and/or stanols or phytostanols and/or glucomannan and/or konjac gum and/or prebiotic fibres and/or fermented red rice and/or betaglucans from oats, oat bran, barley, barley bran and/orgel in lyophilized form.

Bacterial strains belonging to the genusfor use in the treatment of hypercholesterolaemia

A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.

Bacterial strains capable of metabolizing oxalates

A multilayer microencapsulated lactic bacteria and bifidobacteria, preferably bacteria with probiotic activity, and the use thereof to prepare a food product, supplement product, medical device or pharmaceutical composition or water- and/or fruit-based beverage are described. A process for preparing multilayer microencapsulated lactic bacteria and bifidobacteria, preferably bacteria with probiotic activity is described. A food product is described selected from water, water- and/or fruit-based beverages, milk, fresh whole milk, partially skimmed milk, powdered milk, cheese, fresh cheese, aged cheese, grated cheese, butter, margarine, yogurt, cream, milk- and chocolate-based custards, custards for sweets, jams and oily suspensions having bacteria, preferably multilayer microencapsulated lactic bacteria and bifidobacteria with probiotic activity.

Multilayer microencapsulated probiotic bacteria

The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Composition comprising probiotic bacteria for use in the treatment of immune disorders

Selected bacterial strains belonging to the genusfor use in the treatment of hypercholesterolaemia are described. In particular, a food composition or supplement product or medical device or pharmaceutical composition has said bacterial strains in association with sterols or phytosterols and/or stanols or phytostanols and/or glucomannan and/or konjac gum and/or prebiotic fibers and/or fermented red rice and/or betaglucans from oats, oat bran, barley, barley bran and/orgel in lyophilized form.

[object Object]

The present invention relates to an effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections.

Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections

The present invention relates to a selected strain offor use as a medication for the preventive or curative treatment of infections due to Gram-negative bacteria, preferably enterococci, coliforms and

Growing community of inventors

Novara, Italy

Luca Mogna